CYAD Celyad

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Celyad Oncology SA - ADR market cap is $15.91M.

52 week high is the highest price of a stock in the past 52 weeks, or one year. Celyad Oncology SA - ADR 52 week high is $3.07 as of July 26, 2024.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. Celyad Oncology SA - ADR 52 week low is $0.15 as of July 26, 2024.

Celyad Oncology SA - ADR stock price today is $0.60.

Celyad Oncology SA - ADR stock price yesterday was $0.60.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Celyad Oncology SA - ADR’s P/E ratio is -0.43.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Celyad Oncology SA - ADR P/B ratio is 12.1951.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Celyad Oncology SA - ADR's EBITDA is -0.76.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Celyad Oncology SA - ADR 50-day moving average is $0.709.

Celyad Oncology SA - ADR has 17 employees.